Chronic Kidney Disease Observational Database - Taiwan

NCT03619564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-02-22

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a ketoanalogue supplemented very low protein diet on eGFR decline in chronic kidney disease compared to a low protein diet (0.6 g/kg, LPD) or no protein restriction.

Conditions

  • Chronic Kidney Insufficiency

Sponsors & Collaborators

  • Fresenius Kabi

    lead INDUSTRY

Principal Investigators

  • Hrishikesh Kulkarni, Dr. · Fresenius Kabi

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2021-09-28
Completion
2021-09-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03619564 on ClinicalTrials.gov